Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Investing in VICI Properties A Creative Way to Earn Dividend Yield from Caesars Entertainment

Elaine Mendonca by Elaine Mendonca
March 12, 2024
in Breaking News
0
Real-estate-investing
0
SHARES
3
VIEWS
Share on FacebookShare on Twitter

Looking to earn a solid 5.6% dividend yield from Caesars Entertainment without them actually paying a dividend? Consider investing in VICI Properties (NYSE:VICI), one of the major landlords for Caesars. VICI Properties boasts a diverse portfolio of experiential assets, including top gaming properties like Caesars Palace Las Vegas, MGM Grand, and the Venetian Resort Las Vegas.

As of March 12, 2024, VICI Properties pays out a quarterly dividend of $0.415 per share, totaling $1.66 annually, giving investors a juicy 5.6% yield. By putting your money into VICI Properties, you can indirectly profit from the revenue generated by Caesars Entertainment’s properties while enjoying a steady stream of income through dividends.

This clever investment strategy allows you to tap into the growth potential of the gaming and hospitality industry through a unique channel. By leveraging the stability and income potential of real estate investments tied to Caesars Entertainment’s success, you can generate income creatively from a company that typically doesn’t pay out dividends.

CZR Stock Price Declines on March 12, 2024, Trading Near 52-Week Low

On March 12, 2024, CZR stock experienced a slight decrease in its price, trading near the bottom of its 52-week range and below its 200-day simple moving average. The stock opened at $42.60, $0.03 lower than its previous close, and saw a decrease of $0.04, or 0.09%, since the market last closed.

CZR Stock Performance Analysis: Revenue Fluctuations and Net Income Growth in 2024

On March 12, 2024, CZR stock experienced some fluctuations in its performance based on the data provided by CNN Money. The total revenue for the company stood at $11.53 billion for the past year, showing a 6.53% increase compared to the previous year. However, in the fourth quarter of the same year, the total revenue dropped to $2.83 billion, marking a 5.64% decrease from the previous quarter.

Despite the decrease in total revenue in the last quarter, CZR managed to increase its net income significantly. The net income for the past year was $786.00 million, which is a remarkable 187.43% increase compared to the previous year. In the fourth quarter, CZR reported a net income of -$72.00 million, which showed no change from the previous quarter.

Earnings per share (EPS) also saw a positive trend for CZR. The EPS for the past year was $3.64, representing an increase of 186.62% compared to the previous year. In the last quarter, the EPS was -$0.33, showing no change from the previous quarter.

Investors should closely monitor CZR’s financial reports and market trends to make informed decisions regarding their investments in the company.

Tags: CZR
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Mining technology

Usio Inc Reaffirms Fiscal 2023 Revenue Growth Forecast

AI travel

NextTrip Inc Announces Official Transition and Ticker Symbol Change

Unlocking Value: The Economic Potential of Iron-Titanium-Vanadium Projects

Analyst Rob Oliver Reaffirms Neutral Rating on Asana with 20 Price Target

Recommended

Anticipating Navigator Holdings Quarterly Earnings Report Analysts Predict 030 EPS

2 years ago
Sandy Spring Stock

Sandy Spring Bancorp’s Final Chapter: A New Era Under Atlantic Union

3 months ago
Certara Stock

Certara Stock: Regulatory Milestone and Strong Fundamentals Fuel Recovery Hopes

6 months ago
Meta Stock

Meta Faces Mounting Pressure from Regulators and Strategic Shifts

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Vir Biotechnology’s 2026 Pipeline: A Year of Pivotal Clinical Data

Tellurian Acquisition Finalized as Woodside Takes Control

Coherus BioSciences Forges Key Oncology Alliance with Janssen

TCG BDC Investors Await Key Financial Milestones

Navigating Change: Schnitzer Steel’s Digital and Structural Evolution

Akso Health Group Pivots to Oncology with Global Patient Initiative

Trending

Deluxe Stock
Analysis

Deluxe Stock Gains Momentum on Successful Fintech Transition

by Kennethcix
February 6, 2026
0

Deluxe Corporation is successfully shedding its legacy identity as a check-printing specialist. The company's strategic pivot toward...

Hydrofarm Holdings Inc Stock

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

February 6, 2026
Northeast Bancorp Stock

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

February 6, 2026
Vir Biotechnology Stock

Vir Biotechnology’s 2026 Pipeline: A Year of Pivotal Clinical Data

February 6, 2026
Tellurian Stock

Tellurian Acquisition Finalized as Woodside Takes Control

February 6, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Deluxe Stock Gains Momentum on Successful Fintech Transition
  • Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches
  • Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com